pramipexol | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Pramipexol
EDQM

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

dmfs-not-supported-m-2025-05-19

PharmaCompass Sponsored Ads

Contact Supplier

Temad- We think of world-class quality.

Contact Supplier

jdmfs-not-supported-m-2025-04-28

pramipexol

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 24 USDMF, 18 CEP/COS, 2 JDMF, 16 EU WC, 11 KDMF, 11 NDC API, 26 Listed Suppliers, $ API Reference Price

50 API Suppliers
24 USDMF
18 CEP/COS
2 JDMF
16 EU WC
11 KDMF
11 NDC API
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

10 Intermediate Suppliers

10 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

780 FDF Dossiers, 181 FDA Orange Book, 398 Europe, 33 Canada, 70 Australia, 29 South Africa, 69 Listed Dossiers

780 FDF Dossiers
181 FDA Orange Book
398 Europe
33 Canada
70 Australia
29 South Africa
69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 17 SPI Pharma, 9 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 10 BASF, 16 Corel Pharma Chem, 2 DFE Pharma, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 18 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 5 Lubrizol Life Science Health, 11 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 35 Thickeners and Stabilizers, 29 Controlled & Modified Release, 26 Direct Compression, 22 Taste Masking, 22 Solubilizers, 18 Granulation, 16 Co-Processed Excipients, 16 Chewable & Orodispersible Aids, 14 Lubricants & Glidants, 13 Disintegrants & Superdisintegrants, 9 Topical, 9 Film Formers & Plasticizers, 7 API Stability Enhancers, 7 Parenteral, 6 Rheology Modifiers, 5 Empty Capsules, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Coloring Agents

61 Fillers, Diluents & Binders
45 Coating Systems & Additives
35 Thickeners and Stabilizers
29 Controlled & Modified Release
26 Direct Compression
22 Taste Masking
22 Solubilizers
18 Granulation
16 Co-Processed Excipients
16 Chewable & Orodispersible Aids
14 Lubricants & Glidants
13 Disintegrants & Superdisintegrants
9 Topical
9 Film Formers & Plasticizers
7 API Stability Enhancers
7 Parenteral
6 Rheology Modifiers
5 Empty Capsules
5 Emulsifying Agents
4 Vegetarian Capsules
4 Coloring Agents

DIGITAL CONTENT

19 News #PharmaBuzz

19 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 290 Regulatory FDF Prices

2 US Medicaid Prescriptions
290 Regulatory FDF Prices

MARKET PLACE

10 APIs

10 APIs

PATENTS & EXCLUSIVITIES

14 US Patents, 17 Health Canada Patents

14 US Patents
17 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 17 Others

3 EDQM
2 USP
17 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 11,154 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

3 All

01 1Y0001187

02 1Y0001266

03 1Y0001267

filter CAS Number Reset all filters

3 All

01 1104632-27-1

02 2191217-81-9

filter Reference Standard Reset all filters

3 All

01 1Pramipexole dihydrochloride monohydrate

02 1Pramipexole for system suitability

03 1Pramipexole impurity D

Product Main Page

01

EDQM, Council of Europe

Pramipexole for system suitability

STLE Annual Meeting

Not Confirmed

01

EDQM, Council of Europe

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Pramipexole for system suitability

CAS Number : 191217-81-9

Quantity Per Vial : 15 mg

Sale Unit : 1

Order Code : Y0001187

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Pramipexole impurity D

STLE Annual Meeting

Not Confirmed

02

EDQM, Council of Europe

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Pramipexole impurity D

CAS Number : 104632-27-1

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : Y0001267

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Pramipexole dihydrochloride monohydrate

STLE Annual Meeting

Not Confirmed

03

EDQM, Council of Europe

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Pramipexole dihydrochloride monohydrate

CAS Number : 191217-81-9

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : Y0001266

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!